The closing price of Tango Therapeutics Inc (NASDAQ: TNGX) was $7.73 for the day, down -5.96% from the previous closing price of $8.22. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 500233 shares were traded.
Ratios:
Our analysis of TNGX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.54 and its Current Ratio is at 7.54. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on February 12, 2024, initiated with a Overweight rating and assigned the stock a target price of $18.
On December 08, 2023, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $16.
H.C. Wainwright Upgraded its Neutral to Buy on October 20, 2022, while the target price for the stock was maintained at $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 20 ’24 when Third Rock Ventures IV, L.P. sold 162,500 shares for $12.00 per share. The transaction valued at 1,950,000 led to the insider holds 19,201,475 shares of the business.
Weber Barbara sold 4,457 shares of TNGX for $56,246 on Feb 07 ’24. The Chief Executive Officer now owns 1,535,167 shares after completing the transaction at $12.62 per share. On Feb 07 ’24, another insider, Crystal Adam, who serves as the insider of the company, sold 4,083 shares for $12.62 each. As a result, the insider received 51,527 and left with 119,478 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNGX now has a Market Capitalization of 826.00M and an Enterprise Value of 528.03M. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.58 while its Price-to-Book (P/B) ratio in mrq is 3.12. Its current Enterprise Value per Revenue stands at 14.46 whereas that against EBITDA is -4.72.
Stock Price History:
Over the past 52 weeks, TNGX has reached a high of $13.03, while it has fallen to a 52-week low of $2.47. The 50-Day Moving Average of the stock is 11.13, while the 200-Day Moving Average is calculated to be 8.07.
Shares Statistics:
TNGX traded an average of 677.54K shares per day over the past three months and 1.07M shares per day over the past ten days. A total of 102.20M shares are outstanding, with a floating share count of 52.47M. Insiders hold about 50.83% of the company’s shares, while institutions hold 52.08% stake in the company. Shares short for TNGX as of Feb 29, 2024 were 8.87M with a Short Ratio of 13.09, compared to 10.51M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.69% and a Short% of Float of 15.43%.
Earnings Estimates
The firm’s stock currently is rated by 7 analysts. On average, analysts expect EPS of -$0.31 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.33, while EPS last year was -$0.32. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.3 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$1.18 and -$1.44 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$1.41, with 6 analysts recommending between -$1.18 and -$1.62.
